Literature DB >> 19759230

Foot-and-mouth disease virus antigen detection enzyme-linked immunosorbent assay using multiserotype-reactive monoclonal antibodies.

Kazuki Morioka1, Katsuhiko Fukai, Kazuo Yoshida, Reiko Yamazoe, Hiroyuki Onozato, Seiichi Ohashi, Tomoyuki Tsuda, Kenichi Sakamoto.   

Abstract

Monoclonal antibody (MAb)-based sandwich direct enzyme-linked immunosorbent assay (MSD-ELISA) methods that can detect foot-and-mouth disease virus (FMDV) antigens, both multiserotype (MSD-ELISA/MS) (for O, A, C, and Asia 1) and single-serotype (MSD-ELISA/SS) (for O, A, and Asia 1, specifically), were developed. MAb 1H5 was used as an antigen-trapping antibody that reacted with all seven serotypes of FMDV. The MAbs 71F2, 70C4, 16C6, and 7C2 were used as peroxidase-labeled detecting antibodies for multiple serotypes (O, A, C, and Asia 1), type O, type A, and type Asia 1, respectively, in both MSD-ELISA/MS and MSD-ELISA/SS. Our MSD-ELISAs showed high specificity. They produced a very low background of negative samples (buffer, plasma, and saliva) and were able to detect FMDV antigens from clinical samples (plasma and saliva), with results correlating with those of real-time reverse transcription-PCR. In terms of sensitivity, the MSD-ELISAs showed higher optical density values against each diluted serotype antigen than the indirect sandwich ELISA method, which is currently recommended in the manual of the World Organization for Animal Health. The sensitivity and specificity of the MSD-ELISAs seem to be sufficient for the antigenic diagnosis of FMDV.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19759230      PMCID: PMC2772642          DOI: 10.1128/JCM.00695-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Differentiation of the seven serotypes of foot-and-mouth disease virus by reverse transcriptase polymerase chain reaction.

Authors:  M Callens; K De Clercq
Journal:  J Virol Methods       Date:  1997-08       Impact factor: 2.014

2.  Comparison of reverse transcription polymerase chain reaction, enzyme linked immunosorbent assay and virus isolation for the routine diagnosis of foot-and-mouth disease.

Authors:  S M Reid; M A Forsyth; G H Hutchings; N P Ferris
Journal:  J Virol Methods       Date:  1998-02       Impact factor: 2.014

3.  Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis.

Authors:  P L Roeder; P M Le Blanc Smith
Journal:  Res Vet Sci       Date:  1987-09       Impact factor: 2.534

4.  The complete nucleotide sequence of the PanAsia strain of foot-and-mouth disease virus isolated in Japan.

Authors:  Toru Kanno; Makoto Yamakawa; Kazuo Yoshida; Kenichi Sakamoto
Journal:  Virus Genes       Date:  2002-10       Impact factor: 2.332

5.  The complete nucleotide sequence of a pathogenic swine vesicular disease virus isolated in Japan (J1'73) and phylogenetic analysis.

Authors:  T Inoue; S Yamaguchi; T Kanno; S Sugita; T Saeki
Journal:  Nucleic Acids Res       Date:  1993-08-11       Impact factor: 16.971

6.  Outbreaks of swine vesicular disease in japan: virus isolation and epizootiological survey.

Authors:  T Tokui; M Kono; G Tokuda; T Kumagai; J Sasahara
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1975

Review 7.  Characteristics of foot and mouth disease virus in Taiwan.

Authors:  C C Huang; M H Jong; S Y Lin
Journal:  J Vet Med Sci       Date:  2000-07       Impact factor: 1.267

8.  Isolation of foot-and-mouth disease virus from Japanese black cattle in Miyazaki Prefecture, Japan, 2000.

Authors:  Kenichi Sakamoto; Toru Kanno; Makoto Yamakawa; Kazuo Yoshida; Reiko Yamazoe; Yosuke Murakami
Journal:  J Vet Med Sci       Date:  2002-01       Impact factor: 1.267

9.  Determinants of early foot-and-mouth disease virus dynamics in pigs.

Authors:  M Quan; C M Murphy; Z Zhang; S Alexandersen
Journal:  J Comp Pathol       Date:  2004-11       Impact factor: 1.311

10.  Comparison of the characters of the plaque-purified viruses from foot-and-mouth disease virus O/JPN/2000.

Authors:  Kazuki Morioka; Katsuhiko Fukai; Seiichi Ohashi; Kenichi Sakamoto; Tomoyuki Tsuda; Kazuo Yoshida
Journal:  J Vet Med Sci       Date:  2008-07       Impact factor: 1.267

View more
  6 in total

1.  Expression profile of human immune-responsive gene 1 and generation and characterization of polyclonal antiserum.

Authors:  Wei Xiao; Lan Wang; Ruijing Xiao; Mengjun Wu; Jinquan Tan; Yuling He
Journal:  Mol Cell Biochem       Date:  2011-03-20       Impact factor: 3.396

2.  Development and Evaluation of a Rapid Antigen Detection and Serotyping Lateral Flow Antigen Detection System for Foot-and-Mouth Disease Virus.

Authors:  Kazuki Morioka; Katsuhiko Fukai; Kazuo Yoshida; Rie Kitano; Reiko Yamazoe; Manabu Yamada; Tatsuya Nishi; Toru Kanno
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

3.  Specific detection of foot-and-mouth disease serotype Asia 1 virus by carboxyl-magnetic beads conjugated with single-domain antibody.

Authors:  Shunli Yang; Shuanghui Yin; Youjun Shang; Di Wang; Weimin Ma; Jijun He; Jianhong Guo; Jianping Cai; Xiangtao Liu
Journal:  BMC Biotechnol       Date:  2015-09-15       Impact factor: 2.563

4.  Evaluation of monoclonal antibody-based sandwich direct ELISA (MSD-ELISA) for antigen detection of foot-and-mouth disease virus using clinical samples.

Authors:  Kazuki Morioka; Katsuhiko Fukai; Kenichi Sakamoto; Kazuo Yoshida; Toru Kanno
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

Review 5.  Foot-and-mouth disease: past, present and future.

Authors:  Syed M Jamal; Graham J Belsham
Journal:  Vet Res       Date:  2013-12-05       Impact factor: 3.683

6.  Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control.

Authors:  Michiel M Harmsen; Julian Seago; Eva Perez; Bryan Charleston; Phaedra L Eblé; Aldo Dekker
Journal:  Front Immunol       Date:  2017-08-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.